Related content

Pathology and personalized medicine in lung cancer

By Kerr Keith M   Loo Peh Sun   Nicolson Marianne C  

Lung Cancer Management, Vol. 2, Iss. 1, 2013-02 ,pp. : 35-46

Future Medicine

Access to resources Recommend Favorite

Pharmacogenomics of brain cancer and personalized medicine in malignant gliomas

By Mehrian Shai Ruty   Reichardt Juergen KV   Chen Thomas C  

Future Oncology, Vol. 4, Iss. 4, 2008-08 ,pp. : 525-534

Future Medicine

Access to resources Recommend Favorite

Personalized medicine in lung adenocarcinoma: no longer a hope or a passing fashion, but a new reality

By Morère Jean-François  

Targeted Oncology, Vol. 5, Iss. 4, 2010-12 ,pp. : 229-230

Springer Publishing Company

Access to resources Recommend Favorite

Comprehensive genomic analyses of a metastatic colon cancer to the lung by whole exome sequencing and gene expression analysis

By                  

International Journal of Oncology, Vol. 44, Iss. 1, 2014-01 ,pp. : 211-221

Spandidos Publications

Access to resources Recommend Favorite

The landscape of EGFR pathways and personalized management of non-small-cell lung cancer

By Cheng Liang   Zhang Shaobo   Alexander Riley   Yao Yongxue   MacLennan Gregory T   Pan Chong-xian   Huang Jiaoti   Wang Mingsheng   Montironi Rodolfo   Lopez-Beltran Antonio  

Future Oncology, Vol. 7, Iss. 4, 2011-04 ,pp. : 519-541

Future Medicine

Access to resources Recommend Favorite